• Return to Headlines

Cytomx Therapeut Shares Down 33.0% Since SmarTrend's Sell Call (CTMX)

By James Quinn

SmarTrend identified a Downtrend for Cytomx Therapeut (NASDAQ:CTMX) on August 15th, 2018 at $22.40. In approximately 3 months, Cytomx Therapeut has returned 33.02% as of today's recent price of $15.00.

Cytomx Therapeut share prices have moved between a 52-week high of $35.00 and the current low of $0.00 and are currently at $0.00 per share. The 200-day and 50-day moving averages have moved 1.14% lower and 4.78% lower over the past week, respectively.

CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company. The Company focuses on developing probody therapeutics for the treatment of cancer. CytomX Therapeutics serves pharmaceutical industries throughout the United States.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Cytomx Therapeut.

Log in and add Cytomx Therapeut (CTMX) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights cytomx therapeut

Ticker(s): CTMX